Operating Lease, Right-of-Use Asset of Celldex Therapeutics, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Celldex Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Celldex Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $2,717,000, a 14% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Celldex Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,717,000 -$453,000 -14% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $3,121,000 +$671,000 +27% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $3,514,000 +$1,349,000 +62% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $3,898,000 +$1,321,000 +51% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $3,170,000 +$306,000 +11% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $2,450,000 -$806,000 -25% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $2,165,000 -$1,468,000 -40% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 $2,577,000 -$1,424,000 -36% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $2,864,000 -$716,000 -20% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $3,256,000 -$688,000 -17% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $3,633,000 +$1,069,000 +42% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $4,001,000 +$1,031,000 +35% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 $3,580,000 +$564,000 +19% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $3,944,000 +$1,226,000 +45% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $2,564,000 -$524,000 -17% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $2,970,000 -$479,000 -14% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $3,016,000 -$785,000 -21% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $2,718,000 -$416,000 -13% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $3,088,000 -$651,000 -17% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $3,449,000 -$24,000 -0.69% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $3,801,000 +$370,000 +11% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $3,134,000 -$840,000 -21% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $3,739,000 -$706,000 -16% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $3,473,000 31 Dec 2019 10-K 29 Mar 2021 2020 FY
Q3 2019 $3,431,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $3,974,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $4,445,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.